# Rocket Lab Corporation (RKLB) — InvestMoat Analysis _Last analyzed: August 10, 2026_ _Asset class: equity · Canonical page: https://investmoat.com/stocks/rklb_ ## Scores | Dimension | Score (0–100) | | --- | --- | | Moat durability | 52 | | Growth trajectory | 84 | | Valuation | 74 | | **Composite** | **69** | Scores are computed deterministically from this asset’s data by the InvestMoat formula (see https://investmoat.com/llms.txt for methodology). Scores are not directly comparable across asset classes. ## Key stats - **Ticker:** RKLB (Nasdaq) - **Market Cap:** ~$50B ## Moat A narrow-but-real moat from the regulatory and engineering barrier to orbital launch plus a vertically integrated space-systems stack — a clear step below SpaceX and still unproven at medium-lift. Recent Space Force awards deepen the defense franchise but do not yet change the moat statuses. ### The Orbital Barrier + Vertical Stack Rocket Lab's durability is physical, regulatory, and talent-based — not software. **Three** reinforcing pillars, all earlier-stage than an incumbent like SpaceX: - **Regulatory + Capability Barrier:** Reaching orbit is one of the hardest combined regulatory, capital, and engineering barriers in existence. Rocket Lab is one of only a handful of Western companies with an operational orbital launcher — Electron has flown 92 missions (13 in 2026 through early August) — holding FAA launch licences, ITAR clearance, and a NASA/Space Force track record now expanding via HASTE and SB-AMTI awards. The barrier to entry is genuinely high, but Neutron is not yet certified for NSSL and RKLB's franchise remains nascent versus SpaceX, so this is durable rather than dominant. - **Vertical-Integration Stack:** The real differentiator is breadth: launch plus an in-house Space Systems arm (reaction wheels, star trackers, solar arrays, separation systems, radios, and flight software embedded in other operators' and government satellites) plus full spacecraft — now including Flatellite work under SB-AMTI. It is an end-to-end 'space company' bundle competitors must assemble piecemeal, and Space Systems — the larger segment at $136.7M of Q1 revenue — carries higher switching costs than launch. - **Scarce Aerospace Talent:** Reusable propulsion, GNC, and spacecraft-manufacturing expertise is among the scarcest engineering talent in the economy, and Rocket Lab has assembled one of the few teams operating an orbital rocket at cadence. AI augments but does not replace rocket and spacecraft engineers, so this scarcity is AI-resilient — though it is execution, not a structural lock-in. **Moat verdict:** Rocket Lab is a modest net AI beneficiary on the demand side — AI-driven defense, earth-observation, and connectivity buildouts lift launch and satellite-component demand — while its applicable moats (the regulatory/engineering barrier to orbit, scarce aerospace talent, the vertically integrated stack) are essentially AI-irrelevant and therefore AI-resilient. It carries none of the AI-vulnerable software moats (no learned interface, business-logic, public-data, transaction, or system-of-record exposure), so AI cannot erode the durability it has. Recent Space Force awards deepen the defense franchise without changing moat statuses. The honest limitation is that the moat is narrow and execution-dependent: most categories are N/A, the regulatory and data moats are intact rather than strong, and the whole thesis hinges on Neutron flying. Durable enough to be the credible Western #2, but a clear step below SpaceX. ### Top competitors - **[SpaceX (SPCX)](https://investmoat.com/stocks/spacex):** Falcon 9 rideshare dominates small-satellite launch. - **Firefly Aerospace (FLY):** Alpha small launcher and lunar landers. - **Blue Origin:** New Glenn medium-heavy launch against Neutron. ## Growth Latest reported print is still Q1 2026: record $200.3M (+63.5% YoY), Space Systems ($136.7M) outweighing Launch ($63.7M), with Q2 guided to $225–240M (~60% YoY at the midpoint; Street ~$232M) as results land after close today. The $2.2B Q1 backlog underwrites multi-year 40%+ growth before Neutron revenue, and Electron has kept cadence (92nd mission / 13th of 2026 as of Aug 6). Post-quarter Space Force awards ($266M HASTE + $397M SB-AMTI) reinforce the defense pipeline — but SB-AMTI rides on Neutron, which remains NET Q4 2026 after the January tank failure. Rocket Lab is still GAAP loss-making with breakeven not modeled before ~2027, so hypergrowth is real but not yet self-funding. - **Revenue CAGR estimate:** 30–40% - **Primary type:** both - **Margin trend:** stable - **Key risk (high):** Neutron is the linchpin of the re-rating, SB-AMTI delivery, and future NSSL Phase 3 Lane 1 eligibility — yet a January 2026 tank failure already pushed first flight to no-earlier-than Q4 2026. If Neutron does not reach orbit and a credible cadence by end of 2027, the medium-lift, defense, and constellation revenue that justifies a ~50–70× sales multiple slips, and the stock de-rates toward its backlog-supported small-launch-plus-Space-Systems base. - **Drivers:** - Space Systems — $136.7M Q1 2026 (larger segment); Flatellite/SB-AMTI and defense constellation work layering onto components + spacecraft backlog (accelerating) - Launch Services (Electron) — $63.7M Q1 2026; 92 Electron missions overall / 13 in 2026 YTD; HASTE $266M Space Force block buy expands hypersonic cadence (stable) - Neutron (medium-lift, reusable) — Pre-revenue; ~13t to LEO; 5 commercial contracts + SB-AMTI first named defense payload; first flight still NET Q4 2026 (accelerating) - **Score derivation:** Base 91 (~35% blended 3–5yr CAGR, 30%+ band) + ~3 trajectory (Space Systems and Neutron accelerating; Launch stable) + 0 margin (still GAAP loss-making; Neutron R&D offsets gross-margin gains) − 10 high risk (Neutron unproven; tank failure already slipped the debut; SB-AMTI and NSSL eligibility gated on first flight) = 84. ## Valuation At ~$83.60 (~$50B) Rocket Lab trades at roughly ~70× trailing sales (~$680M TTM) and still ~45–55× 2026E sales against a GAAP net loss and no profitability modeled before ~2027 — an extreme multiple that already prices in a successful Neutron. The stock has pulled back from the ~$104 June analysis print and the $151 May high, sitting between our bear ($55) and base ($100) cases and ~25% below Street's ~$111 average target after a sharp pre-earnings rally. Liquidity funds the Neutron ramp but is not a valuation floor — this remains a momentum/optionality holding, not a value one. **Fair value:** $100 (base) — above spot after the pullback; still rich on every sales metric, with upside Neutron-contingent — P/E is omitted — Rocket Lab is GAAP loss-making (net loss ~$45M in Q1 2026) and not expected to reach breakeven until ~2027, so earnings multiples are meaningless. Valuation rests on price/sales (~70× trailing, ~45–55× 2026E) and the credibility of the Neutron-driven forward revenue ramp. The premium is paid for the orbital barrier, the Space Systems stack, and Neutron optionality — not current cash generation. ## Price scenarios ### Bear — $55 Neutron slips materially or fails its debut and the growth-stock multiple compresses: the market refuses to pay 50×+ sales for a loss-making launcher, re-rating the stock toward its backlog-supported base (~35% below spot). - Neutron's first flight slips into 2027 or fails to reach orbit, pushing medium-lift revenue, SB-AMTI delivery, and NSSL eligibility out by a year or more - Price/sales compresses from ~50–70× toward ~25–30× as capital rotates out of unprofitable space names after a disappointing earnings reaction - Continued cash burn on the Neutron ramp forces another dilutive raise despite >$2B liquidity access ### Base — $100 Space Systems keeps compounding and Electron/HASTE hold their niche, Neutron debuts roughly on the Q4 2026 schedule, and the multiple cools toward Street's ~$111 consensus as revenue catches up — fair value near $100 over 12–24 months. - FY2026 revenue lands near $900M–$1.0B (+~40%) on Space Systems strength and backlog conversion, with Q2 printing inside the $225–240M guide - Neutron reaches orbit around Q4 2026 / early 2027 but at low initial cadence, so its revenue contribution is still modest through 2027 - Forward price/sales drifts from ~50× toward ~35–40× as revenue catches up, with the stock working toward ~$100 rather than re-testing the $151 high ### Bull — $165 The flywheel inflects: Neutron succeeds and ramps cadence, SB-AMTI and further defense/constellation wins accelerate, and Rocket Lab re-rates as the credible Western #2 launch-plus-space-systems platform toward and beyond its prior high. - Neutron reaches orbit on or near schedule and scales toward a multi-launch annual cadence, validating the reusable medium-lift cost curve and unlocking NSSL competition - Defense and national-security awards plus constellation/end-to-end mission wins (SB-AMTI and beyond) push backlog and FY2027 revenue toward $1.5B+ - Operating losses narrow sharply toward breakeven, letting the market underwrite a durable-platform premium rather than pure optionality --- InvestMoat is a research and education framework. Nothing here is financial advice. Past performance does not guarantee future results.